- Home
- PMTS vs JSPR Comparison
PMTS vs JSPR Comparison
Compare PMTS & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- JSPR
- Stock Information
- Founded
- PMTS 2007
- JSPR 2018
- Country
- PMTS United States
- JSPR United States
- Employees
- PMTS N/A
- JSPR N/A
- Industry
- PMTS Finance Companies
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMTS Finance
- JSPR Health Care
- Exchange
- PMTS Nasdaq
- JSPR Nasdaq
- Market Cap
- PMTS 332.0M
- JSPR 321.8M
- IPO Year
- PMTS 2015
- JSPR N/A
- Fundamental
- Price
- PMTS $35.04
- JSPR $21.96
- Analyst Decision
- PMTS Strong Buy
- JSPR Strong Buy
- Analyst Count
- PMTS 4
- JSPR 11
- Target Price
- PMTS $34.00
- JSPR $73.38
- AVG Volume (30 Days)
- PMTS 43.2K
- JSPR 176.7K
- Earning Date
- PMTS 11-05-2024
- JSPR 11-07-2024
- Dividend Yield
- PMTS N/A
- JSPR N/A
- EPS Growth
- PMTS N/A
- JSPR N/A
- EPS
- PMTS 1.30
- JSPR N/A
- Revenue
- PMTS $458,377,000.00
- JSPR N/A
- Revenue This Year
- PMTS $9.16
- JSPR N/A
- Revenue Next Year
- PMTS $7.71
- JSPR N/A
- P/E Ratio
- PMTS $26.43
- JSPR N/A
- Revenue Growth
- PMTS N/A
- JSPR N/A
- 52 Week Low
- PMTS $15.00
- JSPR $4.40
- 52 Week High
- PMTS $34.90
- JSPR $31.01
- Technical
- Relative Strength Index (RSI)
- PMTS 69.64
- JSPR 50.34
- Support Level
- PMTS $33.19
- JSPR $19.41
- Resistance Level
- PMTS $34.90
- JSPR $23.11
- Average True Range (ATR)
- PMTS 1.33
- JSPR 1.71
- MACD
- PMTS -0.06
- JSPR -0.15
- Stochastic Oscillator
- PMTS 80.82
- JSPR 38.70
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.